GGrantIndex
← Leaderboards

Cerevel Therapeutics, Llc

Cambridge, MA

Compare ↔
$10,800,000
Total funding
2
Grants

Funding over time

peak $5.4M · FY2021–24
$10M$7.5M$5M$2.5M$0
'21
'22
'23
'24

Funding mix

By agency

NIH$10,800,000 · 2

By mechanism

UG3$5,400,000 · 1
UH3$5,400,000 · 1

Investigators at Cerevel Therapeutics, Llc

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Georgette Suidan$2,700,0001 gr

Emerging Leaders

6–10 yrs in

1Philip Iredale$4,050,0002 gr2Matthew Leoni$4,050,0002 gr

All-Time

Most funded here, all years

1Philip Iredale$4,050,0002 gr2Matthew Leoni$4,050,0002 gr3Georgette Suidan$2,700,0001 gr

Largest grants

CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse$5,400,000
UG3 · FY2021 · DA
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse$2,700,000
UH3 · FY2023 · DA
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse$2,700,000
UH3 · FY2024 · DA